What if Hemophilic Joint Damage Isn’t as Irreversible as We Thought? – RPTH Journal
RPTH Journal shared a post on LinkedIn about a recent article by Parthiv Sheth et al, adding:
“What if hemophilic joint damage isn’t as irreversible as we thought?
For decades, hemophilic arthropathy has been viewed as a one-way path: bleed to damage, damage to progression.
This new longitudinal ultrasound study challenges that narrative.
Using the JADE musculoskeletal ultrasound protocol, researchers followed adults with hemophilia for up to 3 years and tracked cartilage, bone, and soft-tissue changes across elbows, knees, and ankles.
Here’s the surprising part։
- Joint tissues showed dynamic plasticity over time
- Some unhealthy joints actually showed signs of repair
- Hemarthrosis was linked to cartilage thinning and increased PRO-C4 biomarker turnover
- PRO-C4 may signal ongoing synovial vascular remodeling and subclinical bleeding
- Clinical scores barely changed — while ultrasound detected subclinical tissue trajectories
Translation:
- We may finally have tools to see joint biology evolving in real time — not just the end-stage damage.
This work reframes hemophilic arthropathy as a dynamic, remodeling disease, opening the door to earlier intervention, better monitoring, and new outcome measures for trials.”
Tilte: Joint tissue plasticity in hemophilia: insights from the Joint Activity and Damage Exam ultrasound protocol
Authors: Parthiv Sheth, Khang Tong, Bilgimol Chumappumkal Joseph, Tina Manon-Jensen, Michael Glenzer, Isaac Nwi-Mozu, Peter Aguero, Bruno Steiner, Cindy Bailey, Doris V. Quon, Rebecca Kruse-Jarres, Euyhyun Lee, Morten Asser Karsdal, Lin Liu, Annette von Drygalski
Read the Full Article on RPTH Journal.
Find more posts featuring RPTH Journal on Hemostasis Today.
-
Oct 16, 2026, 13:59Aya Akmal Amin: Antiphospholipid Syndrome Management and Risk Stratification
-
Oct 16, 2026, 13:10Emanuel Sueldo: CAHT 2026 Celebrates Scientific Progress and Team Achievements
-
Oct 16, 2026, 13:05Maha Othman: Queen’s Health Sciences Advances CAT Risk Models and Pediatric ISTH-BAT Cut-Offs
-
Oct 16, 2026, 13:03Thrombosis Awareness Must Lead to Timely Action – Roche
-
Oct 16, 2026, 12:49Wolfgang Miesbach: 5-Year CBDR Data Confirms Emicizumab Safety and Efficacy in Hemophilia A
-
Oct 16, 2026, 12:40Edward Lee Carter: How Factor XI Inhibition Could Transform Anticoagulation Therapy
-
Oct 16, 2026, 12:40Marc Carrier: Looking Ahead to ISTH 2027 in Vancouver
-
Oct 16, 2026, 12:30Bob Lempke: How One Blood Donation Can Save Up to Three Lives
-
Oct 16, 2026, 12:30Why VWF Therapies Belong on the EU Critical Medicines List – EHC